Lumican: A new inhibitor of matrix metalloproteinase-14 activity

  • Pietraszek K
  • Chatron-Colliet A
  • Brézillon S
 et al. 
  • 14

    Readers

    Mendeley users who have this article in their library.
  • 12

    Citations

    Citations of this article.

Abstract

We previously showed that lumican regulates MMP-14 expression. The aim of this study was to compare the effect of lumican and decorin on MMP-14 activity. In contrast to decorin, the glycosylated form of lumican was able to significantly decrease MMP-14 activity in B16F1 melanoma cells. Our results suggest that a direct interaction occurs between lumican and MMP-14. Lumican behaves as a competitive inhibitor which leads to a complete blocking of the activity of MMP-14. It binds to the catalytic domain of MMP-14 with moderate affinity (KD∼ 275 nM). Lumican may protect collagen against MMP-14 proteolysis, thus influencing cell-matrix interaction in tumor progression.

Author-supplied keywords

  • Decorin
  • Lumican
  • MMP-14
  • Small leucine-rich proteoglycan

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Katarzyna Pietraszek

  • Aurore Chatron-Colliet

  • Corinne Perreau

  • Anna Jakubiak-Augustyn

  • Hubert Krotkiewski

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free